Article
DDX21 Links BRAFV600E and TERT to Promote Thyroid Cancer Progression.
Thyroid : official journal of the American Thyroid Association - 1 Mar 2026
Chen Mengke, Jiang Ke, Zhang Qi, Xiao Xi, Zhu Lefan, Sang Ye, Hu Guanghui, Yu Shuang, Hong Shubin, Lv Weiming, Xiao Haipeng, Liu Rengyun
Abstract excerpt
BACKGROUND: The coexistence of BRAFV600E and telomerase reverse transcriptase (TERT) promoter alterations has been reported to cooperatively upregulate TERT expression and is well recognized as a biomarker for aggressive thyroid cancer. However, the mechanism underlying their synergistic effect remains elusive. METHODS: TERT-interacting proteins were identified via immunoprecipitation (IP) and mass spectrometry...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
